Back to today’s briefing

Story perspectives

High-Dose Vitamin D May Slow MS Progression

3/23/2025

25 6

Summary

Story summary

A groundbreaking clinical trial reveals that high-dose vitamin D may significantly slow the progression from clinically isolated syndrome (CIS) to multiple sclerosis (MS). Among 303 participants, only 60% in the vitamin D group showed disease activity, compared to 74% in the placebo group. Further research is essential to validate these promising results.

1 of 1

Story summary

A groundbreaking clinical trial reveals that high-dose vitamin D may significantly slow the progression from clinically isolated syndrome (CIS) to multiple sclerosis (MS). Among 303 participants, only 60% in the vitamin D group showed disease activity, compared to 74% in the placebo group. Further research is essential to validate these promising results.